Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era
ConclusionsDiagnosis of CIN2+ decreased in women aged 18–24 years, but not in older women. Both changes in screening and human papillomavirus vaccination could have contributed to the decline of CIN2+ in young women.
Source: American Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Pathology | Vaccines | Women